Old Web
English
Sign In
Acemap
>
Paper
>
Immuno-SABR Reboots the Immune Response in Patients with Metastatic NSCLC and Melanoma in Progression to Anti-PD-1 Therapy
Immuno-SABR Reboots the Immune Response in Patients with Metastatic NSCLC and Melanoma in Progression to Anti-PD-1 Therapy
2020
R. Chicas Sett
J. Zafra Martín
J.F. Castilla Martinez
I. Morales
Daniel A Leon Rodriguez
G Benítez
Marta Lloret
Pedro C Lara
Keywords:
Medicine
Melanoma
Cancer research
Immune system
SABR volatility model
anti pd 1
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]